Insulin aspart improves treatment satisfaction, QOL vs human insulin

PharmacoEconomics & Outcomes News ◽

10.1007/bf03276668 ◽

2003 ◽

Vol 426 (1) ◽

pp. 10-10

Keyword(s):

Human Insulin ◽

Insulin Aspart ◽

Treatment Satisfaction

Download Full-text

Effects of normal human insulin, insulin aspart, and insulin detemir on the lifespan of Caenorhabditis elegans

Diabetologie und Stoffwechsel ◽

10.1055/s-2008-1076341 ◽

2008 ◽

Vol 3 (S 1) ◽

Author(s):

Y Ibrahim ◽

A Schlotterer ◽

G Kukudov ◽

P Humpert ◽

G Rudofsky ◽

...

Keyword(s):

Caenorhabditis Elegans ◽

Human Insulin ◽

Insulin Aspart ◽

Insulin Detemir ◽

Download Full-text

Insulin aspart delivers versus human insulin in pregnancy

Inpharma Weekly ◽

10.2165/00128413-200716120-00016 ◽

2007 ◽

Vol &NA; (1612) ◽

pp. 9

Author(s):

&NA;

Keyword(s):

Human Insulin ◽

Insulin Aspart ◽

Download Full-text

Interindividual Variability in the Pharmacodynamic and Pharmacokinetic Characteristics of Recombinant Human Insulin and Insulin Aspart

Clinical Therapeutics ◽

10.1016/j.clinthera.2021.01.008 ◽

2021 ◽

Author(s):

Ting Li ◽

Hui Liu ◽

Hongling Yu ◽

Jingtao Qiao ◽

Lisi Sun ◽

...

Keyword(s):

Human Insulin ◽

Insulin Aspart ◽

Interindividual Variability ◽

Recombinant Human Insulin

Download Full-text

PDB24 COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO BIPHASIC INSULIN ASPART 30 FROM BIPHASIC HUMAN INSULIN 30 IN THE CZECH SETTING

Value in Health ◽

10.1016/s1098-3015(10)75002-6 ◽

2009 ◽

Vol 12 (7) ◽

pp. A405-A406

Author(s):

E Suchankova ◽

T Doležal ◽

Z Pisarikova ◽

K Rychna ◽

D Bartaskova

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

Cost Effectiveness Analysis ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Effectiveness Analysis ◽

Biphasic Insulin Aspart 30

Download Full-text

Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus

Diabetic Medicine ◽

10.1111/j.1464-5491.2007.02247.x ◽

2007 ◽

Vol 24 (10) ◽

pp. 1129-1135 ◽

Author(s):

D. J. Pettitt ◽

P. Ospina ◽

C. Howard ◽

H. Zisser ◽

L. Jovanovic

Keyword(s):

Diabetes Mellitus ◽

Gestational Diabetes ◽

Gestational Diabetes Mellitus ◽

Human Insulin ◽

Insulin Aspart ◽

Regular Human Insulin

Download Full-text

Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients

Diabetic Medicine ◽

10.1046/j.1464-5491.2002.00733.x ◽

2002 ◽

Vol 19 (5) ◽

pp. 393-399 ◽

Author(s):

B. O. Boehm ◽

P. D. Home ◽

C. Behrend ◽

N. M. Kamp ◽

A. Lindholm

Keyword(s):

Randomized Trial ◽

Human Insulin ◽

Insulin Aspart ◽

Diabetic Patients ◽

Premixed Insulin ◽

Type 2 Diabetic Patients ◽

Type 2 Diabetic

Download Full-text

An analysis of the cost-effectiveness of switching from biphasic human insulin 30, insulin glargine, or neutral protamine Hagedorn to biphasic insulin aspart 30 in people with type 2 diabetes

Journal of Medical Economics ◽

10.3111/13696998.2014.991791 ◽

2015 ◽

Vol 18 (4) ◽

pp. 263-272 ◽

Author(s):

Vishal Gupta ◽

Ranya Baabbad ◽

Eva Hammerby ◽

Annie Nikolajsen ◽

Asrul Akmal Shafie

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Neutral Protamine Hagedorn ◽

Download Full-text

PDB22 LONG-TERM COST-EFFECTIVENESS OF INSULIN ASPART VERSUS SOLUBLE HUMAN INSULIN IN PATIENTS WITH TYPE 1 DIABETES IN THE UNITED KINGDOM

Value in Health ◽

10.1016/s1098-3015(10)62955-5 ◽

2005 ◽

Vol 8 (3) ◽

pp. 358-359 ◽

Author(s):

ME Minshall ◽

NS Twena ◽

L Nicklasson ◽

S Roze

Keyword(s):

Type 1 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

The United Kingdom

Download Full-text

A Comparison of Pharmacokinetics and Pharmacodynamics of Insulin Aspart, Biphasic Insulin Aspart 70, Biphasic Insulin Aspart 50, and Human Insulin: A Randomized, Quadruple Crossover Study

Diabetes Technology & Therapeutics ◽

10.1089/dia.2011.0299 ◽

2012 ◽

Vol 14 (7) ◽

pp. 589-595 ◽

Author(s):

Zhulin Ma ◽

Tina Parkner ◽

Jan Frystyk ◽

Torben Laursen ◽

Torsten Lauritzen ◽

...

Keyword(s):

Crossover Study ◽

Human Insulin ◽

Insulin Aspart ◽

Pharmacokinetics And Pharmacodynamics ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin

Download Full-text

PDB24 ASSESSMENT OF THE LONG-TERM COST-EFFECTIVENESS OF INSULIN ASPART + METFORMIN VERSUS HUMAN INSULIN + METFORMIN REGIMENS IN TYPE-2 DIABETES IN GERMANY BASED ON THE CLINICAL FINDINGS OF THE PHAZIT STUDY

Value in Health ◽

10.1016/s1098-3015(10)67643-7 ◽

2005 ◽

Vol 8 (6) ◽

pp. A161-A162

Author(s):

S Roze ◽

KU Wittrup-Jensen ◽

C Haüser ◽

WJ Valentine ◽

AJ Palmer

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

Clinical Findings

Download Full-text